Citigroup
INBX icon

Citigroup’s Inhibrx INBX Stock Holding History

Citigroup’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.4M Buy
164,324
+88,603
+117% +$8.84M 0.01% 1312
2026
Q2 		$7.17M Buy
75,721
+13,205
+21% +$1.32M ﹤0.01% 1851
2026
Q1 		$4.2M Buy
62,516
+6,757
+12% +$501K ﹤0.01% 2099
2025
Q4 		$4.4M Buy
55,759
+50,788
+1,022% +$3.46M ﹤0.01% 2105
2025
Q3 		$167K Buy
4,971
+1,639
+49% +$40.4K ﹤0.01% 4062
2025
Q2 		$47.5K Sell
3,332
-5,177
-61% -$66.9K ﹤0.01% 4784
2025
Q1 		$119K Sell
8,509
-1,464
-15% -$19.9K ﹤0.01% 4497
2024
Q4 		$154K Buy
9,973
+673
+7% +$10.3K ﹤0.01% 4592
2024
Q3 		$146K Buy
9,300
+5,108
+122% +$71.8K ﹤0.01% 4570
2024
Q2 		$59.4K Buy
+4,192
New +$65.5K ﹤0.01% 4485

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Citigroup's INBX Position: Q3 2026 in Review

Citigroup increased its Inhibrx (INBX) stake by 117% in Q3 2026, buying an estimated $8.84M and bringing the position to 164,324 shares worth $16.4M. The position accounts for 0.01% of the portfolio, ranked #1312.

Citigroup first reported a position in INBX in Q2 2024 and has held it in 10 quarters since. 50 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Citigroup held 164,324 shares of Inhibrx worth $16.4M as of Q3 2026.
  • Citigroup bought 88,603 Inhibrx shares in Q3 2026, an estimated $8.84M.
  • Inhibrx made up 0.01% of Citigroup's portfolio in Q3 2026, its #1312 holding.
  • Citigroup first reported a position in Inhibrx in Q2 2024 and has held it in 10 quarters since.
  • 50 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.